Informationen:
Fehler:
ID
34985
Beschreibung
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With FGF Aberrant Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02202746
Link
https://clinicaltrials.gov/show/NCT02202746
Stichworte
Versionen (1)
- 06.02.19 06.02.19 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
6. Februar 2019
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Breast Cancer NCT02202746
Eligibility Breast Cancer NCT02202746
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Breast Cancer NCT02202746
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
BREAST CANCER METASTATIC RECURRENT | Secondary malignant neoplasm of female breast Unresponsive to Standard therapy
Item
histologically or cytologically confirmed metastatic breast cancer relapsed or refractory to approved standard available treatment
boolean
C0741681 (UMLS CUI [1])
C0346993 (UMLS CUI [2,1])
C0205269 (UMLS CUI [2,2])
C2936643 (UMLS CUI [2,3])
C0346993 (UMLS CUI [2,1])
C0205269 (UMLS CUI [2,2])
C2936643 (UMLS CUI [2,3])
First line treatment Standard Neoplasm Metastasis
Item
prior treatment with standard first line therapy in the metastatic setting
boolean
C1708063 (UMLS CUI [1,1])
C1442989 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
C1442989 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
Availability of Tumor tissue sample | FGFR1 Gene Amplification Testing | 11q Amplification Testing
Item
availability of tumor tissue sufficient for confirmatory testing of fgfr1 and 11q amplification status
boolean
C0470187 (UMLS CUI [1,1])
C0475358 (UMLS CUI [1,2])
C1517090 (UMLS CUI [2,1])
C0039593 (UMLS CUI [2,2])
C0796366 (UMLS CUI [3,1])
C1521871 (UMLS CUI [3,2])
C0039593 (UMLS CUI [3,3])
C0475358 (UMLS CUI [1,2])
C1517090 (UMLS CUI [2,1])
C0039593 (UMLS CUI [2,2])
C0796366 (UMLS CUI [3,1])
C1521871 (UMLS CUI [3,2])
C0039593 (UMLS CUI [3,3])
Disease Progression | Measurable Disease
Item
demonstrated progression of disease by radiological or clinical assessment (measurable disease according to recist version 1.1 is not required for enrollment)
boolean
C0242656 (UMLS CUI [1])
C1513041 (UMLS CUI [2])
C1513041 (UMLS CUI [2])
Life Expectancy
Item
estimated life expectancy >6 months
boolean
C0023671 (UMLS CUI [1])
Cancer treatment biological
Item
current or recent treatment with biologic anticancer therapies
boolean
C0920425 (UMLS CUI [1,1])
C0205460 (UMLS CUI [1,2])
C0205460 (UMLS CUI [1,2])
Adverse events Due to Cancer treatment
Item
ongoing aes from prior anticancer therapies
boolean
C0877248 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0920425 (UMLS CUI [1,3])
C0678226 (UMLS CUI [1,2])
C0920425 (UMLS CUI [1,3])
CNS metastases
Item
active central nervous system (cns) metastases
boolean
C0686377 (UMLS CUI [1])
Hypertensive disease Clinical Significance | Uncontrolled hypertension | Heart Disease Clinical Significance | Heart Disease Uncontrolled
Item
clinically significant or uncontrolled hypertension or cardiac disease
boolean
C0020538 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
C1868885 (UMLS CUI [2])
C0018799 (UMLS CUI [3,1])
C2826293 (UMLS CUI [3,2])
C0018799 (UMLS CUI [4,1])
C0205318 (UMLS CUI [4,2])
C2826293 (UMLS CUI [1,2])
C1868885 (UMLS CUI [2])
C0018799 (UMLS CUI [3,1])
C2826293 (UMLS CUI [3,2])
C0018799 (UMLS CUI [4,1])
C0205318 (UMLS CUI [4,2])
Pregnancy | Breast Feeding
Item
females who are pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Chemotherapy Quantity Neoplasm Metastasis
Item
for cohort c (biomarker-negative) patients: greater than 3 lines of previous chemotherapy in the metastatic setting
boolean
C0392920 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])